From Data to Diagnosis

Revela Health is developing software to enable the fast, non-invasive detection of endometriosis, a painful condition affecting millions of women, which often takes many years to diagnose.

The company was founded by Molly Jowsey and Tom Willshare, who both have a track record in medical diagnostics and an interest in how data can be used to enhance diagnostic procedures and outcomes. Having seen the significant challenges faced by a family member in receiving an endometriosis diagnosis, Molly realised this was an area in which they could use data to make a real difference.

Their research established that, in most cases, patients with pelvic pain will be given an ultrasound scan, but typically this will look for signs of cancer, fibroids and cysts, often leaving endometriosis undiagnosed and leading to many women going on to have more invasive procedures to diagnose the condition.

However, the vast amount of recorded data available from ultrasound scans offered Revela the opportunity to develop machine learning algorithms capable of significantly speeding up the diagnostic process and helping the millions of women searching for answers for their pelvic pain.